Cargando…
Characterization of Schu S4 aro mutants as live attenuated tularemia vaccine candidates
There is a need for development of an effective vaccine against Francisella tularensis, as this potential bioweapon has a high mortality rate and low infectious dose when delivered via the aerosol route. Moreover, this Tier 1 agent has a history of weaponization. We engineered targeted mutations in...
Autores principales: | Cunningham, Aimee L., Mann, Barbara J., Qin, Aiping, Santiago, Araceli E., Grassel, Christen, Lipsky, Michael, Vogel, Stefanie N., Barry, Eileen M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7161688/ https://www.ncbi.nlm.nih.gov/pubmed/32241221 http://dx.doi.org/10.1080/21505594.2020.1746557 |
Ejemplares similares
-
Characterization of Francisella tularensis Schu S4 defined mutants as live-attenuated vaccine candidates
por: Santiago, Araceli E., et al.
Publicado: (2015) -
Low Dose Vaccination with Attenuated Francisella tularensis Strain SchuS4 Mutants Protects against Tularemia Independent of the Route of Vaccination
por: Rockx-Brouwer, Dedeke, et al.
Publicado: (2012) -
Modern Development and Production of a New Live Attenuated Bacterial Vaccine, SCHU S4 ΔclpB, to Prevent Tularemia
por: Conlan, J. Wayne, et al.
Publicado: (2021) -
Deletion of the Major Facilitator Superfamily Transporter fptB Alters Host Cell Interactions and Attenuates Virulence of Type A Francisella tularensis
por: Balzano, Phillip M., et al.
Publicado: (2018) -
Identification of an Attenuated Substrain of Francisella tularensis SCHU S4 by Phenotypic and Genotypic Analyses
por: Lovchik, Julie A., et al.
Publicado: (2021)